Logo image
Sign in
Quality of Life Outcomes of a Randomized, Placebo-Controlled Trial of Bevacizumab in the Front-Line Treatment of Ovarian Cancer: a Gynecologic Oncology Group Study
Journal article   Peer reviewed

Quality of Life Outcomes of a Randomized, Placebo-Controlled Trial of Bevacizumab in the Front-Line Treatment of Ovarian Cancer: a Gynecologic Oncology Group Study

B.J. Monk, H. Huang, R.A. Burger, R.L. Mannel, H.D. Homesley, J. Fowler, B.E. Greer, M. Boente, S.X. Liang and L. Wenzel
European journal of cancer (1990), Vol.47, pp.12-12
2011

Metrics

1 Record Views

Details